Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Antituberculosis drugs: drug interactions, adverse effects, and use in special situations Part 2: second line drugs Arbex MA; Varella Mde C; Siqueira HR; Mello FAJ Bras Pneumol 2010[Sep]; 36 (5): 641-56The main objectives of tuberculosis therapy are to cure the patients and to minimize the possibility of transmission of the bacillus to healthy subjects. Adverse effects of antituberculosis drugs or drug interactions (among antituberculosis drugs or between antituberculosis drugs and other drugs) can make it necessary to modify or discontinue treatment. We describe the general mechanism of action, absorption, metabolization, and excretion of the drugs used to treat multidrug resistant tuberculosis (aminoglycosides, fluoroquinolones, cycloserine/terizidone, ethionamide, capreomycin, and para-aminosalicylic acid). We describe adverse drug reactions and interactions (with other drugs, food, and antacids), as well as the most appropriate approach to special situations, such as pregnancy, breastfeeding, liver failure, and kidney failure.|Antitubercular Agents/adverse effects/pharmacokinetics/*therapeutic use[MESH]|Drug Interactions[MESH]|Female[MESH]|Food-Drug Interactions[MESH]|Humans[MESH]|Pregnancy[MESH]|Pregnancy Complications/drug therapy[MESH]|Tuberculosis, Multidrug-Resistant/drug therapy[MESH]|Tuberculosis/*drug therapy[MESH] |